Improving Global Access to Life Changing Therapeutics

Navigating Global Access Strategy, Regulatory Complexity & Post-Trial Access to Build Sustainable, Scalable Expanded Access Programs

Expanded Access is entering a new phase. Post-Trial Access is moving earlier into planning, real-world data is creating new opportunities for evidence generation, and reimbursement, launch timelines and global expansion are widening the decisions EAP teams need to make. As programs become more interconnected with the wider development journey, teams need greater confidence that the decisions they make today will remain workable as patient numbers, markets and expectations change.

The 7th Operationalize: Expanded Access Programs Summit is the dedicated forum for the people responsible for turning these increasingly complex access requirements into programs that work in practice. Join 150+ leaders from pharma, biotech and the wider EAP community in Boston to benchmark your approach against peers, challenge how your organization is working and learn directly from those delivering access today.

Move beyond high-level discussion to explore the realities shaping EAP delivery, from Post-Trial Access, real-world data and regulatory complexity to reimbursement, supply, program exits, patient continuity, digital innovation and advanced therapies. Hear how different organizations are responding, where approaches diverge and what teams are learning from programs already underway.

Combined with purpose-built networking designed to connect you with relevant experience in the room, OEAP gives you practical ideas, stronger industry benchmarks and an EAP community you can continue drawing on long after Boston.

This conference is a vibrant space where pharma and service providers unite to share knowledge, spark innovation, and build the collaborations that will shape tomorrow’s breakthrough EAPs. It's very exciting!

Chief Scientific Officer, Early Access Care

It was great to hear different perspectives on managed access with several panels from different sizes of companies. It was truly a great environment for all.

Oncology Managed Access Manager, GSK

The presenters were great and came well prepared to answer any questions. I also enjoyed how everyone was so engaged with the speakers and asked many valuable questions.

Associate Director, Clinical Operations

It was my first time at this conference and it was a wealth of knowledge that I assimilated. Meeting some of the best minds in this space of early/expanded access was so very insightful.

Co-Founder, Sowaka Health

The collaborative spirit of attendees is always a huge draw to this conference.

Director, Research Grants & Expanded Access, Alkermes

It was my first time participating in this event, and I truly appreciated the opportunity to network and share the challenges we face in our daily work. It made us feel less alone!

Global Early Access Manager, Ipsen Pharma

The conference was very well attended and the range of topics was broad and insightful.

Associate Director, Jazz Pharmaceuticals

The open exchange of best practices among high caliber experts in the fields is a standard in this conference series. The prominent presence of the patient caregivers is reminding us all why it is important to work and continuing building this space.

Patient Access Program & Supply Lead, Roche